Next-Generation Vascular Closure System

Publication ID: 24-11857172_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Vascular Closure System,” Published Technical Disclosure No. 24-11857172_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857172_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,172.

Summary of the Inventive Concept

A futuristic vascular closure system leveraging advanced materials, robotics, and AI to provide enhanced biocompatibility, precision, and real-time monitoring for improved patient outcomes.

Background and Problem Solved

The original patent disclosed a vascular closure device with limitations in terms of biocompatibility, deployment precision, and real-time monitoring. The new inventive concept addresses these limitations by integrating cutting-edge technologies to provide a more effective and efficient vascular closure system.

Detailed Description of the Inventive Concept

The next-generation vascular closure system comprises a bio-absorbable vascular closure device with a shape-memory alloy framework that self-expands upon deployment. The device features a nanotechnology-based coating for enhanced biocompatibility and reduced inflammation. The system utilizes a robotic-assisted catheter system and real-time imaging feedback to ensure precise placement and minimize complications. The device has a modular design, allowing for the addition or removal of secondary closure elements to adapt to varying vascular anatomy and closure requirements. The system also integrates an artificial intelligence-powered deployment algorithm that adjusts deployment parameters in real-time based on patient-specific data and vascular anatomy. Furthermore, the system includes an integrated sensor for real-time monitoring of vascular closure and potential complications, with data analytics provided through a cloud-based platform.

Novelty and Inventive Step

The new claims introduce several novel and non-obvious features, including the use of shape-memory alloy frameworks, nanotechnology-based coatings, robotic-assisted deployment, real-time imaging feedback, modular design, AI-powered deployment algorithms, and integrated sensors with cloud-based data analytics. These advancements significantly improve the efficiency, effectiveness, and safety of vascular closure procedures.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different materials or coatings, variations in the robotic-assisted deployment system, or modifications to the AI-powered deployment algorithm. Additionally, the system could be adapted for use in other medical procedures or applications.

Potential Commercial Applications and Market

The next-generation vascular closure system has significant commercial potential in the medical device industry, particularly in the areas of interventional cardiology and vascular surgery. The system's advanced features and improved patient outcomes could lead to widespread adoption and market growth.

CPC Classifications

SectionClassGroup
A A61 A61B17/0057
A A61 A61B2017/00004
A A61 A61B2017/00623

Field of Art

Medical device engineering, specifically vascular closure technologies, involving interventional cardiology, minimally invasive surgical techniques, and biomaterial design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degrees in bioengineering, expertise in medical device design, knowledge of vascular anatomy, materials science, and familiarity with minimally invasive surgical technologies

Obviousness Rationale

A PHOSITA would recognize that the PTD's advanced vascular closure system represents predictable technological improvements to the source patent's fundamental vascular closure device design. The disclosed variations leverage known engineering techniques and emerging medical technologies to enhance existing closure device functionality. The modifications represent incremental advancements that would be obvious to a skilled practitioner seeking to optimize vascular closure procedures.

Obvious Combinations & Variations

Source Patent Element
Self-expanding tubular vascular closure element with a patch configured to close a vascular access hole
PTD Variation
Bio-absorbable vascular closure device with shape-memory alloy framework that self-expands upon deployment
Obviousness Reasoning
Material substitution using known shape-memory alloys is a predictable design choice for improving device performance and biocompatibility
Source Patent Element
Retaining element surrounding the vascular closure element
PTD Variation
Modular design allowing selective addition or removal of secondary closure elements to adapt to varying vascular anatomy
Obviousness Reasoning
Modular medical device designs are well-known in the art, representing an obvious extension of existing closure device configurations
Source Patent Element
Tether mechanism for controlling deployment of closure device
PTD Variation
AI-powered deployment algorithm adjusting parameters in real-time based on patient-specific data and vascular anatomy
Obviousness Reasoning
Integration of computational intelligence into medical device control systems is a known technique for improving precision and adaptability
Source Patent Element
Vascular closure device for sealing access holes
PTD Variation
Robotic-assisted catheter system with real-time imaging feedback for precise placement
Obviousness Reasoning
Combining robotic technologies with existing medical devices represents a predictable advancement in minimally invasive surgical techniques
Source Patent Element
Basic vascular closure device design
PTD Variation
Nanotechnology-based coating for enhanced biocompatibility and reduced inflammation
Obviousness Reasoning
Surface modification using nanomaterials is a known strategy for improving medical device performance and patient outcomes
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857172 and the comprehensive technical disclosure herein, a person having ordinary skill in the art would find the claimed variations obvious and predictable extensions of existing vascular closure device technologies. The disclosed innovations represent incremental improvements utilizing known engineering techniques, materials, and computational methods that would be readily apparent to a skilled practitioner in the field of medical device design.

Original Patent Information

Patent NumberUS 11,857,172
TitleVascular closure device and method of closing a vascular access hole using such a device
Assignee(s)Angiomed GmbH & Co. Medizintechnik KG